PETX News and Press, Aratana Therapeutics Inc. From 05/08/19

LEAWOOD, Kan. , May 8, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, announced its first quarter 2019 financial results and recent business high...

LEAWOOD, Kan. , May 7, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at the Stifel Dental & Veterinary Conference on We...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 102 weeks of public selections as part of this ongoing live forward-testing. In...

In the past two years, I have written several times about Aratana Therapeutics (Nasdaq: PETX ) – a pet therapeutics company that is focused on developing and commercializing innovative therapeutics for cats and dogs. So far, an investment in Aratana Therapeutics was not so lucrative ...

Portola Pharmaceuticals ( PTLA ) - The company announced that the European Commission granted conditional Marketing Authorization for Ondexxya (andexanet alfa) to be used in adult patients treated with the Factor Xa inhibitor apixaban or rivaroxaban when reversal of anticoagulation is needed...

Merger activity decreased last week with three new deals announced and one pending deal closing. Deal Statistics: New Deals The acquisition of The KeyW Holding Corporation (KEYW) by Jacobs Engineering Group (JEC) for $815 million or $11.25 per share in cash. The acquisition ...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 102 weeks of public selections as part of this ongoing live forward-testing. In...

NEW YORK, April 26, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the sale of Aratana Therapeutics, Inc. (“Aratana” or the “Company”) (NASDAQ: PETX) to Elanco Animal Health (“Elanco ...

Gainers:  Aratana Therapeutics (NASDAQ: PETX ) +37% . India Globalization Capital (NYSEMKT: IGC ) +30% . Regional Health Properties (NYSEMKT: RHE ) +32% . Helen of Troy (NASDAQ: HELE ) +21% . Sonic Automotive (NYSE: SAH ) +15% . Repligen (NASDAQ: RGEN ) +15% . IMV (NASDAQ: IMV )...

Aratana Therapeutics (NASDAQ: PETX ) +37%  on Elanco takeover . More news on: Aratana Therapeutics, Inc., Regional Health Properties, Inc., Reebonz Holding Limited, Stocks on the move, Read more ...